Received: from westeu12-emailsignatures-cloud.codetwo.com (13.93.42.39) by DB5PEPF00014B92.mail.protection.outlook.com (10.167.8.230) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.113.7 via Frontend Transport; Mon, 8 Jun 2026 05:23:14 +0000 Received: from DB5PEPF00014B92.eurprd02.prod.outlook.com (2603:10a6:10:4b7:cafe::30) by DUZPR01CA0303.outlook.office365.com (2603:10a6:10:4b7::27) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.92.13 via Frontend Transport; Mon, 8 Jun 2026 05:23:15 +0000 Received: from DB3PR08CU002.outbound.protection.outlook.com (40.93.64.80) by westeu12-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Mon, 08 Jun 2026 05:23:13 +0000 Received: from DB9PR02MB6697.eurprd02.prod.outlook.com ([fe80::2c1:6459:93f7:d2e4]) by DB9PR02MB6697.eurprd02.prod.outlook.com ([fe80::2c1:6459:93f7:d2e4%6]) with mapi id 15.21.0092.011; Mon, 8 Jun 2026 05:23:11 +0000 Received: from DB9PR02MB6697.eurprd02.prod.outlook.com (2603:10a6:10:214::18) by PAWPR02MB10168.eurprd02.prod.outlook.com (2603:10a6:102:369::6) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.92.7; Mon, 8 Jun 2026 05:23:11 +0000 Received: from DB9PR02MB8348.eurprd02.prod.outlook.com (2603:10a6:10:397::6) by DB9PR02MB6697.eurprd02.prod.outlook.com with HTTPS; Mon, 8 Jun 2026 05:23:17 +0000 Received: from DUZPR01CA0303.eurprd01.prod.exchangelabs.com (2603:10a6:10:4b7::27) by DB9PR02MB8348.eurprd02.prod.outlook.com (2603:10a6:10:397::6) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.92.12; Mon, 8 Jun 2026 05:23:15 +0000 From: "MSO - RA" To: "Regionaalhaigla Info" , "kliinikumkliinikum.ee" , , , , , , , , , , , , , , , , , , "Mart Saluvere" , , "Gerli Raieste" References: In-Reply-To: Subject: Meditsiiniseadmete ohutusalane info - mai 2026 Date: Mon, 8 Jun 2026 08:23:11 +0300 Keywords: Renate, Delta Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0044_01DD07FF.312E5D80" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQIxgaZ8H9vOxb8s1FltelbsHp71UAHU5Svy Authentication-Results: spf=pass (sender IP is 13.93.42.39) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; X-MS-Has-Attach: X-MS-TNEF-Correlator: x-ms-traffictypediagnostic: DB9PR02MB6697:EE_|PAWPR02MB10168:EE_|DB5PEPF00014B92:EE_|DB9PR02MB8348:EE_|DB9PR02MB6697:EE_ X-MS-Office365-Filtering-Correlation-Id: 595eaaa4-facc-4f7f-10d1-08dec51e0a5a X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|31052699007|39142699007|366016|13003099007|8096899003|22082099003|18002099003|921020|55112099003|11063799006|56012099006|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:DB9PR02MB6697.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(31052699007)(39142699007)(366016)(13003099007)(8096899003)(22082099003)(18002099003)(921020)(55112099003)(11063799006)(56012099006)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: lHS6RLmY3ckGLeAFs4gJ3WgBcW5mteazUAr6i9JN2/I/HUe0hnunceYGHa5DS6L28230fXZN5Y1umokGuii3p2k31wmBpUeU/QQ2BBRtzqcFW1WxJcg7XCDwHUrBneIFKJyNcxKxEAunAxGHM6MzgpynVAZcqul9t5H3AKpKh97zaaLskqgfmGjfwTDAOJd0/EZCc9XH4peYxpqUvDWe0e9hzsQeEutqYVRBf6c1FqQP7pD9D1omU161ukulx29UOnW+ZlSv5KpjrTFSSi1npzUsf2aeSyLpAp4/ohdIUxVT8M+DrjvsSKAqKZmbEJkI2TLNjC3ELyf78GNzc1z1dA== X-MS-Exchange-Transport-CrossTenantHeadersStamped: PAWPR02MB10168 X-MS-Exchange-Transport-CrossTenantHeadersStamped: DB9PR02MB8348 X-MS-Exchange-Organization-ExpirationStartTime: 08 Jun 2026 05:23:14.6554 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 595eaaa4-facc-4f7f-10d1-08dec51e0a5a X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-Exchange-Transport-CrossTenantHeadersStripped: DB5PEPF00014B92.eurprd02.prod.outlook.com X-MS-PublicTrafficType: Email X-MS-Exchange-Organization-AuthSource: DB9PR02MB6697.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id-Prvs: 308b81c3-b9d5-4577-bd29-08dec51e08a9 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|366016|39142699007|35042699022|31052699007|82310400026|921020|55112099003|8096899003|11063799006|56012099006|13003099007|18002099003|22082099003|41050700001; X-Forefront-Antispam-Report: CIP:13.93.42.39;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu12-emailsignatures-cloud.codetwo.com;PTR:westeu12-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(366016)(39142699007)(35042699022)(31052699007)(82310400026)(921020)(55112099003)(8096899003)(11063799006)(56012099006)(13003099007)(18002099003)(22082099003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 08 Jun 2026 05:23:14.6061 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 595eaaa4-facc-4f7f-10d1-08dec51e0a5a X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DB9PR02MB6697.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-EndToEndLatency: 00:00:03.1267479 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0092.005 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 X-Message-Completed: Tue, 9 Jun 2026 12:43:41 +0300 Content-Language: et x-ms-exchange-organization-originalserveripaddress: 10.167.8.230 x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-06-08T05:23:11.006Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 13.93.42.39 as permitted sender) receiver=protection.outlook.com; client-ip=13.93.42.39; helo=westeu12-emailsignatures-cloud.codetwo.com; pr=C X-OlkEid: 00000000FBE30D4A7ED77B47974B2304BB4E84D8070034AD76187591974DBF6C4F76951C873A0100030000000000B3D5AF184A00AB4C8C167C2EB8411B9B000000000C380000878C48E1F6F09F4DB2B0644FBF7E2C7C X-OrganizationHeadersPreserved: PAWPR02MB10168.eurprd02.prod.outlook.com X-CodeTwo-MessageID: 37e0a709-e0fd-4a76-8170-dd3e905b104d.20260608052313@westeu12-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-Organization-Recipient-P2-Type: Bcc X-CrossPremisesHeadersPromoted: DB5PEPF00014B92.eurprd02.prod.outlook.com X-CrossPremisesHeadersFiltered: DB5PEPF00014B92.eurprd02.prod.outlook.com X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[13.93.42.39];Helo=[westeu12-emailsignatures-cloud.codetwo.com] This is a multipart message in MIME format. ------=_NextPart_000_0044_01DD07FF.312E5D80 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Tere! Anname teada, et mai 2026 meile teatatud meditsiiniseadmete valdkonna parandusmeetmete ülevaade on nüüd avaldatud Ravimiameti kodulehel ohutusalase teabe rubriigis: https://www.ravimiamet.ee/meditsiiniseadmed/ettevotjale/ohutusalane-teave. Meditsiiniseadme tootja (või levitaja) kohustus on viivitamatult teavitada oma kasutajaid parandusmeetmetest, mistõttu on enamik teateid Teile tõenäoliselt juba teada. Meie avaldame ülevaate Eestit puudutavatest juhtumitest dubleerivalt, et tagada teabe kättesaadavus kõigile. Teie küsimused on alati teretulnud. Lugupidamisega Renate Saare Ravimiamet meditsiiniseadmete osakond spetsialist Tel 7 374 140 renate.saare@ravimiamet.ee Nooruse 1 50411 Tartu www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have recieved. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. _____ Tere! Anname teada, et aprill 2026 meile teatatud meditsiiniseadmete valdkonna parandusmeetmete ülevaade on nüüd avaldatud Ravimiameti kodulehel ohutusalase teabe rubriigis: https://www.ravimiamet.ee/meditsiiniseadmed/ettevotjale/ohutusalane-teave. Meditsiiniseadme tootja (või levitaja) kohustus on viivitamatult teavitada oma kasutajaid parandusmeetmetest, mistõttu on enamik teateid Teile tõenäoliselt juba teada. Meie avaldame ülevaate Eestit puudutavatest juhtumitest dubleerivalt, et tagada teabe kättesaadavus kõigile. Teie küsimused on alati teretulnud. Parimate soovidega Renate Saare Ravimiamet meditsiiniseadmete osakond spetsialist Tel 7 374 140 renate.saare@ravimiamet.ee Nooruse 1 50411 Tartu www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have recieved. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. ------=_NextPart_000_0044_01DD07FF.312E5D80 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable
Tere!
 
Anname teada, et mai 2026 meile teatatud meditsiiniseadmete valdkonna = parandusmeetmete =C3=BClevaade on n=C3=BC=C3=BCd avaldatud Ravimiameti = kodulehel ohutusalase teabe rubriigis: https://www.ravimiamet.ee/meditsiiniseadmed/ettevotjale/ohutusalane-teave= .  
Meditsiiniseadme tootja (v=C3=B5i levitaja) kohustus on viivitamatult = teavitada oma kasutajaid parandusmeetmetest, mist=C3=B5ttu on enamik = teateid Teile t=C3=B5en=C3=A4oliselt juba teada. Meie avaldame = =C3=BClevaate Eestit puudutavatest juhtumitest dubleerivalt, et tagada = teabe k=C3=A4ttesaadavus k=C3=B5igile.
 
Teie k=C3=BCsimused on alati teretulnud.



Lugupidamisega

Renate Saare

Ravimiamet

meditsiiniseadmete osakond

spetsialist

Tel 7 374 140

renate.saare@ravimiamet.ee

 

Nooruse 1

50411 Tartu

www.ravimiamet.ee 

 

Selles e-kirjas sisalduv teave (kaasa arvatud = manused) on m=C3=B5eldud ametialaseks kasutamiseks ning seda v=C3=B5ivad = kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt v=C3=A4ljendatud loata edasi saata ega mis = tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud = k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, teavitage sellest koheselt = saatjat ning kustutage e-kiri.
This e-mail and any attachments transmitted may contain confidential and = privileged information.  If you are not the intended recipient, = please notify the sender immediately by returning the e-mail and = permanently deleting what you have recieved. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal.






Tere!

 

Anname teada, et aprill 2026 meile teatatud = meditsiiniseadmete valdkonna parandusmeetmete =C3=BClevaade on = n=C3=BC=C3=BCd avaldatud Ravimiameti kodulehel ohutusalase teabe = rubriigis: https://www.ravimiamet.ee/meditsiiniseadmed/ettevotjale/ohutusalane-teave= .  

Meditsiiniseadme tootja (v=C3=B5i levitaja) kohustus = on viivitamatult teavitada oma kasutajaid parandusmeetmetest, = mist=C3=B5ttu on enamik teateid Teile t=C3=B5en=C3=A4oliselt juba teada. Meie avaldame =C3=BClevaate Eestit puudutavatest juhtumitest = dubleerivalt, et tagada teabe k=C3=A4ttesaadavus = k=C3=B5igile.

 

Teie k=C3=BCsimused on alati teretulnud.

 

 

Parimate soovidega

Renate Saare

Ravimiamet

meditsiiniseadmete osakond

spetsialist

Tel 7 374 140

renate.saare@ravimiamet.ee

 

Nooruse 1

50411 Tartu

www.ravimiamet.ee

 

Selles e-kirjas sisalduv teave (kaasa arvatud = manused) on m=C3=B5eldud ametialaseks kasutamiseks ning seda v=C3=B5ivad = kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt v=C3=A4ljendatud loata edasi saata ega mis = tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud = k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, teavitage sellest koheselt = saatjat ning kustutage e-kiri.
This e-mail and any attachments = transmitted may contain confidential and privileged information.  = If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you = have recieved. Any dissemination or use of this information by a third = person without permission is prohibited and may be illegal.


------=_NextPart_000_0044_01DD07FF.312E5D80--